Ayuda
Ir al contenido

Dialnet


Modulació de la síntesi i de la dinàmica d'emmagatzematge presinàptica de dopamina per antipsicòtics agonistes parcials de receptors d2 a l'estriat cerebral de rata

  • Autores: Muhammad Yusof Omar
  • Directores de la Tesis: Jordi Ortiz de Pablo (dir. tes.)
  • Lectura: En la Universitat Autònoma de Barcelona ( España ) en 2020
  • Idioma: español
  • ISBN: 9788449096488
  • Tribunal Calificador de la Tesis: Enrique Claro Izaguirre (presid.), Francisco Ciruela Alférez (secret.), Analía Bortolozzi Biasoni (voc.)
  • Programa de doctorado: Programa de Doctorado en Bioquímica, Biología Molecular y Biomedicina por la Universidad Autónoma de Barcelona
  • Materias:
  • Enlaces
    • Tesis en acceso abierto en: TDX
  • Resumen
    • Presynaptic dopaminergic regulation is important to maintain a homeostatic balance of dopamine stored levels and release. Changes in dopamine neurotransmission contribute to neurological and psychiatric disorders. Recent findings from our group (Ma et al., 2015; González-Sepúlveda et al.,-submitted) describe strong effects of several classes of dopaminergic drugs on dopamine synthesis, including L-DOPA (used in Parkinson), tetrabenazine (Huntington) and aripiprazole (schizophrenia). In this study, I confirm and extend those findings and compare the effects of D2R partial agonist antipsychotics cariprazine and brexpiprazole, the psychostimulants amphetamine and methylphenidate, and several other selective and experimental compounds. Rat brain striatum was minced and incubated ex-vivo in the presence or absence of these drugs at different concentrations. Spontaneously, dopamine and serotonin accumulated over time reaching near-maximal storage levels. This experimental approach allowed me to evaluate their synthesis and storage dynamics under the influence of chosen pharmacological agents. My results could be useful to understand the mechanisms of action of antipsychotics, and they could facilitate further research with animal models and clinical trials using new dopaminergic agents.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno